| 53-86-1 |
| indometacin |
| Indocin |
| Indomethacine |
| Indometacine |
| Indocid |
| Reumacide |
| Indomethazine |
| Metindol |
| Artrinovo |
| Confortid |
| Idomethine |
| Indomecol |
| Indomethacinum |
| Metartril |
| Methazine |
| Artrivia |
| Dolovin |
| Imbrilon |
| Indacin |
| Indomed |
| Indomee |
| Indoptol |
| Infrocin |
| Metacen |
| Sadoreum |
| Amuno |
| Inacid |
| Tannex |
| Indo-rectolmin |
| Inteban sp |
| Artracin |
| Durametacin |
| Indoptic |
| Inflazon |
| Mikametan |
| Lausit |
| Mezolin |
| Mobilan |
| Indo-tablinen |
| Indo-Lemmon |
| Indometacinum |
| Indometacyna |
| Indometicina |
| Indocin Sr |
| Indometacina |
| Aconip |
| 2-(1-(4-Chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl)acetic acid |
| Indmethacine |
| Dolcidium |
| Elmetacin |
| Indomethine |
| Indorektal |
| Tivorbex |
| Catlep |
| Indoxen |
| Vonum |
| Indo-phlogont |
| Chibro-amuno |
| Bonidon Gel |
| Dolcidium PL |
| Rheumacin LA |
| 1H-Indole-3-acetic acid, 1-(4-chlorobenzoyl)-5-methoxy-2-methyl- |
| Osmosin |
| 1-(p-Chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid |
| CCRIS 3502 |
| HSDB 3101 |
| Indometacine [INN-French] |
| Indometacinum [INN-Latin] |
| Indometacina [INN-Spanish] |
| FLAM |
| Inteban |
| 1-(4-Chlorobenzoyl)-5-methoxy-2-methyl-3-indoleacetic acid |
| NCI-C56144 |
| UNII-XXE1CET956 |
| 2-[1-(4-chlorobenzoyl)-5-methoxy-2-methylindol-3-yl]acetic acid |
| EINECS 200-186-5 |
| XXE1CET956 |
| MFCD00057095 |
| Indometacin [INN] |
| NSC-757061 |
| 1-(p-Chlorobenzoyl)-2-methyl-5-methoxyindole-3-acetic acid |
| BRN 0497341 |
| USAN |
| 1-(4-Chlorobenzoyl)-5-methoxy-2-methyl-1H-indole-3-acetic acid |
| Indomethacin (Indocid, Indocin) |
| CHEBI:49662 |
| CHEMBL6 |
| NSC-77541 |
| IMN |
| Indole-3-acetic acid, 1-(p-chlorobenzoyl)-5-methoxy-2-methyl- |
| Indomethacin [USAN:USP] |
| alpha-(1-(p-Chlorobenzoyl)-2-methyl-5-methoxy-3-indolyl)acetic acid |
| 2-{1-[(4-chlorophenyl)carbonyl]-5-methoxy-2-methyl-1h-indol-3-yl}acetic acid |
| N-p-Chlorbenzoyl-5-methoxy-2-methylindole-3-acetic acid |
| MLS000069402 |
| DTXSID9020740 |
| (1-p-Chlorobenzoyl-5-methoxy-2-methylindol-3-yl)acetic acid |
| 1-(p-chlorobenzoyl)-5-methoxy-2-methyl-3-indolylacetic acid |
| 1-(p-Chlorobenzoyl)-2-methoxy-3-methyl-1H-indole-3-acetic Acid |
| Indomet 140 |
| EC 200-186-5 |
| [1-(4-Chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]acetic acid |
| 5-22-05-00239 (Beilstein Handbook Reference) |
| {1-[(4-chlorophenyl)carbonyl]-5-methoxy-2-methyl-1H-indol-3-yl}acetic acid |
| NSC 757061 |
| CAS-53-86-1 |
| 1-p-Cloro-benzoil-5-metoxi-2-metilindol-3-acido acetico |
| NCGC00015562-18 |
| Indomethancin |
| 1-(4-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid |
| Arthrexin |
| Bonidin |
| Bonidon |
| Indameth |
| Indomod |
| Miametan |
| SMR000058195 |
| Indomo |
| Flexin continus |
| Hicin |
| Kwas 1-(p-chlorobenzoilo)-2-metylo-5-metoksy-3-indolilooctowy |
| Chrono-indicid |
| Chrono-indocid |
| Indometacyna [Polish] |
| Indometicina [Spanish] |
| 2-[1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]acetic acid |
| Indo-Spray |
| Indomethacin (USAN:USP) |
| Indolar SR |
| Indometacine (INN-French) |
| Indometacinum (INN-Latin) |
| Indometacina (INN-Spanish) |
| INDOMETACIN (MART.) |
| INDOMETACIN [MART.] |
| DTXCID50740 |
| INDOMETHACIN (USP-RS) |
| INDOMETHACIN [USP-RS] |
| 1-(p-chlorobenzoyl)-2-methyl-5-methoxy-3-indoleacetic acid |
| 1-(p-Chlorobenzoyl)-5-methoxy-2-methyl-Indole-3-acetic acid |
| INDOMETACIN (EP MONOGRAPH) |
| INDOMETACIN [EP MONOGRAPH] |
| INDOMETHACIN (USP MONOGRAPH) |
| INDOMETHACIN [USP MONOGRAPH] |
| 2-[1-(4-chlorobenzoyl)-5-methoxy-2-methyl-indol-3-yl]acetic acid |
| (1-(4-CHLOROBENZOYL)-5-METHOXY-2-METHYL-1H-INDOL-3-YL)ACETIC ACID |
| 2-{1-[(4-chlorophenyl)carbonyl]-5-methoxy-2-methylindol-3-yl}acetic acid |
| Indocin-SR |
| Indochron E-R |
| Indocin (TN) |
| ACEMETACIN IMPURITY B (EP IMPURITY) |
| ACEMETACIN IMPURITY B [EP IMPURITY] |
| Aconip (TN) |
| Indomethacin (USP) |
| NSC77541 |
| Indocid (pharmaceutical) |
| SR-01000000014 |
| Indomethacin & MAP-30 |
| Indocollyre |
| Indonol |
| Innamit |
| IndomethacinER |
| Indomethacin ER |
| 2-{1-((4-chlorophenyl)carbonyl)-5-methoxy-2-methylindol-3-yl}acetic acid |
| 4kyk |
| (1-((4-chlorophenyl)carbonyl)-5-methoxy-2-methyl-1H-indol-3-yl)acetic acid |
| Indomethacin,(S) |
| Prestwick_597 |
| INDREN |
| Indometacinum (Latin) |
| Opera_ID_56 |
| Spectrum_000919 |
| Tocris-1708 |
| 1z9h |
| 1-(p-Chlorbenzoyl)-5-methoxy-2-methylindol-3-essigsaeure [German] |
| 1-p-Cloro-benzoil-5-metoxi-2-metilindol-3-acido acetico [Spanish] |
| Prestwick0_000272 |
| Prestwick1_000272 |
| Prestwick2_000272 |
| Prestwick3_000272 |
| Spectrum2_000970 |
| Spectrum3_000468 |
| Spectrum4_000018 |
| Spectrum5_000868 |
| INDOMETACIN [JAN] |
| INDOMETHACIN [MI] |
| Lopac-I-7378 |
| Kwas 1-(p-chlorobenzoilo)-2-metylo-5-metoksy-3-indolilooctowy [Polish] |
| CHRONO-INDOCID 75 |
| MolMap_000032 |
| UPCMLD-DP023 |
| I 7378 |
| Indometacin (JP17/INN) |
| INDOMETHACIN [HSDB] |
| INDOMETHACIN [USAN] |
| SCHEMBL9300 |
| INDOMETHACIN [VANDF] |
| Indomethacin Extended-release |
| Lopac0_000692 |
| Oprea1_686105 |
| BSPBio_000144 |
| BSPBio_001149 |
| BSPBio_002176 |
| INDOMETACIN [WHO-DD] |
| INDOMETACIN [WHO-IP] |
| Indomethacine impurity mixture |
| KBioGR_000395 |
| KBioGR_000489 |
| KBioSS_000489 |
| KBioSS_001399 |
| MLS001074194 |
| MLS006011845 |
| BIDD:GT0132 |
| DivK1c_000271 |
| SPECTRUM1500350 |
| SPBio_000979 |
| SPBio_002363 |
| BPBio1_000160 |
| GTPL1909 |
| Indomethacin, >=99% (TLC) |
| UPCMLD-DP023:001 |
| BDBM17638 |
| CGIGDMFJXJATDK-UHFFFAOYSA- |
| HMS500N13 |
| KBio1_000271 |
| KBio2_000489 |
| KBio2_001399 |
| KBio2_003057 |
| KBio2_003967 |
| KBio2_005625 |
| KBio2_006535 |
| KBio3_000897 |
| KBio3_000898 |
| KBio3_001396 |
| 1-(p-Chlorbenzoyl)-5-methoxy-2-methylindol-3-essigsaeure |
| C01EB03 |
| M01AB01 |
| M02AA23 |
| S01BC01 |
| Indomethacin - CAS 53-86-1 |
| NINDS_000271 |
| Bio2_000405 |
| Bio2_000885 |
| HMS1362I11 |
| HMS1568H06 |
| HMS1792I11 |
| HMS1920F21 |
| HMS1990I11 |
| HMS2089N19 |
| HMS2091N09 |
| HMS2095H06 |
| HMS2231J10 |
| HMS3262K05 |
| HMS3268A14 |
| HMS3374F07 |
| HMS3403I11 |
| HMS3414N13 |
| HMS3430L03 |
| HMS3649K17 |
| HMS3655O04 |
| HMS3678N11 |
| HMS3712H06 |
| HMS3747K21 |
| HMS3884E08 |
| INDOMETHACIN [ORANGE BOOK] |
| Indomethacin-d4(chlorobenzoyl-d4) |
| Pharmakon1600-01500350 |
| BCP18951 |
| Indomethacin, >=99.0% (TLC) |
| Tox21_113109 |
| Tox21_201791 |
| Tox21_300266 |
| Tox21_500692 |
| AC-532 |
| CCG-40186 |
| HB4422 |
| INDOMETACINUM [WHO-IP LATIN] |
| NSC757061 |
| s1723 |
| AKOS000592893 |
| Tox21_113109_1 |
| AT13679 |
| DB00328 |
| Indometacin 1.0 mg/ml in Acetonitrile |
| KS-5255 |
| LP00692 |
| SDCCGSBI-0050670.P005 |
| IDI1_000271 |
| IDI1_002160 |
| NCGC00015562-01 |
| NCGC00015562-02 |
| NCGC00015562-03 |
| NCGC00015562-04 |
| NCGC00015562-05 |
| NCGC00015562-06 |
| NCGC00015562-07 |
| NCGC00015562-08 |
| NCGC00015562-09 |
| NCGC00015562-10 |
| NCGC00015562-11 |
| NCGC00015562-12 |
| NCGC00015562-13 |
| NCGC00015562-14 |
| NCGC00015562-15 |
| NCGC00015562-16 |
| NCGC00015562-17 |
| NCGC00015562-19 |
| NCGC00015562-20 |
| NCGC00015562-21 |
| NCGC00015562-22 |
| NCGC00015562-24 |
| NCGC00015562-25 |
| NCGC00015562-40 |
| NCGC00024135-02 |
| NCGC00024135-04 |
| NCGC00024135-05 |
| NCGC00024135-06 |
| NCGC00024135-07 |
| NCGC00024135-08 |
| NCGC00024135-09 |
| NCGC00024135-10 |
| NCGC00024135-11 |
| NCGC00024135-12 |
| NCGC00024135-13 |
| NCGC00024135-14 |
| NCGC00024135-15 |
| NCGC00254075-01 |
| NCGC00259340-01 |
| NCGC00261377-01 |
| BI166166 |
| BP-30207 |
| HY-14397 |
| NCI60_041708 |
| SBI-0050670.P004 |
| AB00052022 |
| EU-0100692 |
| FT-0603227 |
| I0655 |
| SW196768-5 |
| EN300-16807 |
| Indomethacin, meets USP testing specifications |
| BIM-0050670.0001 |
| C01926 |
| D00141 |
| S00108 |
| AB00052022-20 |
| AB00052022-21 |
| AB00052022_23 |
| AB00052022_24 |
| L000959 |
| Q409231 |
| Indomethacin, Antibiotic for Culture Media Use Only |
| Q-201239 |
| SR-01000000014-2 |
| SR-01000000014-4 |
| SR-01000000014-6 |
| 1-(4-Chlorobenzoyl)-5-methoxy-2-met hyl-1H-indole |
| BRD-K57222227-001-06-1 |
| BRD-K57222227-001-18-6 |
| BRD-K57222227-001-27-7 |
| SR-01000000014-10 |
| SR-01000000014-16 |
| Z56784896 |
| 1-p-chlorobenzoyl-2-methyl-5-methoxyindol-3-acetic acid |
| 1-(p-chlorobenzoyl)-5-methoxy-2-methyl-3-indoleacetic acid |
| 1-(p-Chlorobenzoyl)-5-methoxy-2-methylindol-3-acetic acid |
| 1-(4-chloro-benzoyl)-5-methoxy-2-methyl-3-indolyl-acetic acid |
| 1-(4-Chlorobenzoyl)-2-methyl-5-methoxyindole-3-acetic acid |
| 1-(p-Chlorobenzoyl)-2-methyl-5-methoxy-3-indole-acetic acid |
| 1-(p-chlorobenzoyl)-2-methyl-5-methoxy-3-indolylacetic acid |
| 1-(p-chlorobenzoyl)-5-methoxy-2-methyl-3-indol acetic acid |
| Indomethacin, European Pharmacopoeia (EP) Reference Standard |
| N-(p-Chlorobenzoyl)-2-methyl-5-methoxy-3-indolylacetic acid |
| 1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1-H-indole-3-acetic acid |
| Indomethacin, United States Pharmacopeia (USP) Reference Standard |
| N-P-CHLOROBENZOYL-5-METHOXY-2-METHYLINDOLE-3-ACETIC ACID |
| .alpha.-(1-(p-Chlorobenzoyl)-2-methyl-5-methoxy-3-indolyl)acetic acid |
| [1-(4-Chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]acetic acid # |
| 1-(4-Chlorobenzoyl)-5-methoxy-2-methyl-1H-indole-3-acetic acid & MAP-30 |
| 1H-Indole-3-acetic acid, 1-(4-chlorobenzoyl)-5-methoxy-2-methyl- (9CI) |
| 2-{1-[(4-chlorophenyl)carbonyl]-5-methoxy-2 methylindol-3-yl}acetic acid |
| 2-{1-[(4-chlorophenyl)carbonyl]-5-methoxy-2methylindol-3-yl}acetic acid |
| Indole-3-acetic acid, 1-(p-chlorobenzoyl)-5-methoxy-2-methyl- (8CI) |
| Indomethacin, Pharmaceutical Secondary Standard; Certified Reference Material |
| InChI=1/C19H16ClNO4/c1-11-15(10-18(22)23)16-9-14(25-2)7-8-17(16)21(11)19(24)12-3-5-13(20)6-4-12/h3-9H,10H2,1-2H3,(H,22,23) |
|
There are more than 10 synonyms. If you wish to see them all click here.
|
